Aquestive Therapeutics Inc (AQST) — Strategic Asset Allocation Index
Aquestive Therapeutics Inc (AQST) has a Strategic Asset Allocation Index of 121.1% as of December 2018. Strategic assets (PP&E of $12.21 Million plus long-term investments of $-) total $12.21 Million, measured against net assets of $10.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Aquestive Therapeutics Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Aquestive Therapeutics Inc Strategic Asset Allocation Index (2005–2018)
This chart shows how Aquestive Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2005 to 2018. As of December 2018, the index stands at 121.1%, representing strategic assets of $12.21 Million against net assets of $10.08 Million USD. For live market cap and overall valuation, see AQST company net worth.
Annual Strategic Asset Allocation Index for Aquestive Therapeutics Inc (2005–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Aquestive Therapeutics Inc from 2005 to 2018, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Aquestive Therapeutics Inc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 121.1% | $12.21 Million | $12.21 Million | $- | $10.08 Million | ▲ +87.2 pp |
| 2006 | 33.9% | $8.56 Million | $8.56 Million | $- | $25.26 Million | ▼ -129.3 pp |
| 2005 | 163.2% | $7.61 Million | $7.61 Million | $- | $4.67 Million | — |